{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T09:27:21Z","timestamp":1786613241700,"version":"build-2736575974"},"reference-count":130,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100009217","name":"Clarkson University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and aims<\/jats:title>\n                    <jats:p>Between 2000 and 2022, annual opioid overdose fatalities in the United States rose from 10\u2009000 per year to over 80\u2009000 per year. It is generally agreed that a major contributing factor to the US opioid crisis was the increased and widespread availability of the prescription opioid oxycodone during the 1990s and early 2000s. While the opioid crisis and oxycodone's contribution to it have been well documented, it remains underappreciated just how early after its introduction this drug's tendency towards diversion, misuse, dependence and addiction became apparent. This paper reviews the scientific and public health literature that accumulated during the 20th century indicating oxycodone's addiction liability to be of equivalent concern to that of morphine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A narrative review drawing from original scientific, clinical and public health literature obtained from digital archives relevant to the period of interest.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings and conclusions<\/jats:title>\n                    <jats:p>Attention was first drawn to oxycodone's addiction liability by concerned clinicians as early as two years after the drug became commercially available in Germany in 1917, with additional evidence accumulating both in that country and abroad over the subsequent decades. This, combined with research conducted under the supervision of the Committee on Drug Addiction and Narcotics (CDAN) within the Medical Sciences Division of the US National Research Council, led to global recognition of the fact that oxycodone should not be considered any less an addiction liability than morphine. Concerns raised by clinicians about oxycodone throughout that period, and speculation on the causal factors underlying the rapid increase in oxycodone's misuse frequency, are reminiscent of those accepted as contributory to the current global opioid crisis, including lax prescription practices, misleading marketing strategies and inconsistent government oversight. Attempts to draw on this early body of evidence to influence drug policy regarding oxycodone were undermined by a tendency to assess the addiction potential of drug formulations independently of their active ingredients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/add.70560","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T08:37:33Z","timestamp":1786610253000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The (very) early evidence of oxycodone addiction liability"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5349-146X","authenticated-orcid":false,"given":"Damien S. K.","family":"Samways","sequence":"first","affiliation":[{"name":"Department of Biology Clarkson University  Potsdam NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8088-8721","authenticated-orcid":false,"given":"Zachary","family":"Blatchford","sequence":"additional","affiliation":[{"name":"Department of Biology Clarkson University  Potsdam NY USA"},{"name":"DeBusk College of Osteopathic Medicine Lincoln Memorial University  Harrogate TN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"crossref","unstructured":"SpencerM GarnettM Mini\u00f1oA.Drug overdose deaths in the United States 2002\u20132022. Atlanta GA;2023Dec.https:\/\/doi.org\/10.15620\/cdc:135849","DOI":"10.15620\/cdc:135849"},{"key":"e_1_2_11_3_1","unstructured":"SchnellM.The opioid crisis: tragedy treatments and trade\u2010offs. Stanford Institute for Economic Policy Research2019Feb; [accessed 16 Apr 2026]. Available from:https:\/\/siepr.stanford.edu\/publications\/policy-brief\/opioid-crisis-tragedy-treatments-and-trade-offs"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2007.131714"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2115714119"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2021.100031"},{"issue":"10324","key":"e_1_2_11_7_1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(21)02252-2","article-title":"Responding to the opioid crisis in North America and beyond: recommendations of the Stanford\u2010lancet commission","volume":"399","author":"Humphreys K","year":"2022","journal-title":"Lancet"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-031914-122957"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/psychoactives2040020"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1508818"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/qje\/qjab043"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1902811"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.20529\/IJME.2019.043"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(86)90091-6"},{"key":"e_1_2_11_15_1","first-page":"169","article-title":"Current issues in the management of cancer pain: Memorial Sloan\u2010Kettering Cancer Center","volume":"36","author":"Foley KM","year":"1981","journal-title":"NIDA Res Mon Ser"},{"key":"e_1_2_11_16_1","doi-asserted-by":"crossref","DOI":"10.7208\/chicago\/9780226731919.001.0001","volume-title":"White market drugs: big pharma and the hidden history of addiction in America","author":"Herzberg D","year":"2020"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198001103020221"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(82)90016-1"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1977.hed1701012.x"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1700150"},{"issue":"2","key":"e_1_2_11_21_1","first-page":"127","article-title":"The addiction potential of oxycodone (Percodan)","volume":"99","author":"Bloomquist ER","year":"1963","journal-title":"Calif Med"},{"key":"e_1_2_11_22_1","unstructured":"HerzbergD.The history of pharmaceutical opioids in the U.S : from crisis to control to crisis. The People of the State of California v. Purdue Pharma L. P. et al. Case No. 30\u20132014\u2010000725287\u2010CU\u2010BT\u2010CXC. 2020. [accessed 15 May 2025]. Available from:https:\/\/www.industrydocuments.ucsf.edu\/docs\/ylyh0352\/"},{"key":"e_1_2_11_23_1","unstructured":"Advisory committee on traffic in opium and other dangerous drugs.Revised list of drugs preparations and proprietary medicines coming under the international drug conventions. League of Nations;1939.80\u201381p. [accessed 20 May 2025]. Available from:https:\/\/archive.org\/details\/LoN1939-C.348.M.263.1939.XI\/page\/n77\/mode\/2up"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/prac.19160940112"},{"issue":"22","key":"e_1_2_11_25_1","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/BF01742272","article-title":"\u00d6ffentliche Massnahmen Gegen den Missbrauch von Bet\u00e4ubungsmitteln","volume":"6","author":"Jo\u00ebl E","year":"1927","journal-title":"Klin Wochenschr"},{"issue":"12","key":"e_1_2_11_26_1","first-page":"381","article-title":"Eukodal, ein neues Narkotikum","volume":"64","author":"Falk E","year":"1917","journal-title":"Munch Med Wochenschr"},{"issue":"51","key":"e_1_2_11_27_1","first-page":"819","article-title":"Eukodal als Narkotikum","volume":"38","author":"Hesse W","year":"1917","journal-title":"Zentralbl Inn Med"},{"issue":"51","key":"e_1_2_11_28_1","first-page":"642","article-title":"Ueber die erfahrungen mit dem narkotikum \u2018Eukodal\u2019","volume":"64","author":"Rothschild MF","year":"1917","journal-title":"Munch Med Wochenschr"},{"key":"e_1_2_11_29_1","first-page":"219","article-title":"Unsere Erfahrungen mit Eukodal","volume":"33","author":"Baumm F","year":"1919","journal-title":"Ther Monatshefte"},{"issue":"7","key":"e_1_2_11_30_1","first-page":"185","article-title":"Das neue Narkotikum Eukodal","volume":"144","author":"Siegfried","year":"1918","journal-title":"Dtsch Med Wochenschr"},{"issue":"14","key":"e_1_2_11_31_1","first-page":"820","article-title":"Eukodalismus","volume":"56","author":"K\u00f6nig","year":"1919","journal-title":"Berl Klin Wochenschr"},{"issue":"19","key":"e_1_2_11_32_1","first-page":"464","article-title":"Eukodalismus","volume":"56","author":"Falk E","year":"1919","journal-title":"Berl Klin Wochenschr"},{"key":"e_1_2_11_33_1","first-page":"91","article-title":"Uber Gewehnung an Kodeinderivate (Eukodal u. Parakodin)","volume":"111","author":"Biberfeld J","year":"1920","journal-title":"Biochem Z"},{"key":"e_1_2_11_34_1","first-page":"180","article-title":"Eukodal, ein neues narkotikum","volume":"33","author":"Falk E","year":"1919","journal-title":"Ther Monatsh"},{"key":"e_1_2_11_35_1","first-page":"873","article-title":"Ueber Eukodalismus","volume":"67","author":"Alexander A","year":"1920","journal-title":"Munch Med Wochenschr"},{"key":"e_1_2_11_36_1","first-page":"908","article-title":"Ueber Erfahrungen mit Eukodal","volume":"70","author":"Beck O","year":"1923","journal-title":"Munch Med Wochenschr"},{"key":"e_1_2_11_37_1","first-page":"133","article-title":"Ueber Eukodalismus","volume":"71","author":"Meyer M","year":"1924","journal-title":"Munch Med Wochenschr"},{"issue":"3","key":"e_1_2_11_38_1","first-page":"57","article-title":"Tod durch Eukodalismus","volume":"47","author":"Lemperg F","year":"1926","journal-title":"Zentralbl Inn Med"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe0904243"},{"key":"e_1_2_11_40_1","first-page":"236","volume-title":"Heroin : the treatment of addiction in twentieth\u2010century Britain","author":"Mold A","year":"2008"},{"key":"e_1_2_11_41_1","first-page":"751","article-title":"Ueber Eukodalismus","volume":"71","author":"Frensdorf","year":"1927","journal-title":"Munch Med Wochenschr"},{"key":"e_1_2_11_42_1","volume-title":"The opium problem","author":"Terry CE","year":"1928"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1177\/002204268601600308"},{"key":"e_1_2_11_44_1","first-page":"276","volume-title":"Creating the American junkie : addiction research in the classic era of narcotic control","author":"Acker CJ","year":"2002"},{"issue":"6","key":"e_1_2_11_45_1","first-page":"224","article-title":"Zur Behandlung und Bek\u00e4mpfung der Alkaloidsuchten (Morphinismus, Kokainismus usw.) Pt IV","volume":"54","author":"Wolff P","year":"1928","journal-title":"Dtsch Med Wochenschr"},{"issue":"1","key":"e_1_2_11_46_1","first-page":"173","article-title":"Eukodal\u2010Vergiftung, chronische. (Eukodalismus.)","volume":"3","author":"Menninger\u2010Lerchenthal E","year":"1932","journal-title":"Samml Vergiftungsf"},{"key":"e_1_2_11_47_1","volume-title":"Handbuch der Geisteskrankheiten","author":"Meggendorfer F","year":"1928"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02455133"},{"key":"e_1_2_11_49_1","unstructured":"Knaffl\u2010LenzE.Encodal and Dicodid \u2010 Encodal and Dicodid \u2010 Dr. Knaffl\u2010Lenz \u2010 Note regarding the classification of these drugs with morphine and heroin as habitat forming drugs. Vols R733\u201012A\u201014316\u201334256 United Nations Archives Geneva1924. [accessed 14 May 2025]. Available from:https:\/\/archives.ungeneva.org\/encodal-and-dicodid-dr-knaffl-lenz-note-regarding-the-classification-of-these-drugs-with-morphine-and-heroin-as-habitat-forming-drugs"},{"key":"e_1_2_11_50_1","unstructured":"Application of Article 10 of the Opium Convention of February 19th 1925 (Eucodal\u2010Dicotide).1930Oct. [accessed 17 Dec 2025]. Available from:https:\/\/www.google.com\/books\/edition\/Health_Committee\/auHmAAAAMAAJ?hl=en&gbpv=1"},{"key":"e_1_2_11_51_1","unstructured":"Henniker\u2010HeatonH.A law further to amend the law relating to dangerous drugs. 53 United Kingdom ; Oct 15 1932. [accessed 26 Jun 2024]. Available from:https:\/\/www.cylaw.org\/nomoi\/arith\/1932_1_053.pdf"},{"key":"e_1_2_11_52_1","unstructured":"Westminster Wisdom.The chemist and druggist.1932;339. [accessed 26 Jun 2024]. Available from:https:\/\/archive.org\/details\/b19974760M2836\/page\/338"},{"key":"e_1_2_11_53_1","unstructured":"Knaffl\u2010LenzE.Concerning the possible ways of producing codeinone derivatives and (eucodal docotide and acedicon). United Nations Archives.1929;R3158\/12\/15811\/804. [accessed 15 Jan 2026]. Available from:https:\/\/archives.ungeneva.org\/application-of-article-10-of-the-opium-convention-of-1925-eucodal-and-dicodide-enquiry-of-health-committee-1929m-regarding-transformation-of-other-drugs-into-eucodal-and-dicodide"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1522-8649(03)50051-8"},{"key":"e_1_2_11_55_1","unstructured":"Caduceus. Vol. 7 Issue 1.1928. [accessed 15 Jan 2026]. Available from:https:\/\/www.google.com\/books\/edition\/The_Caduceus\/aM9XAAAAMAAJ?hl=en&gbpv=1"},{"key":"e_1_2_11_56_1","article-title":"Eukodal","volume":"300","author":"Department of Commerce","year":"1922","journal-title":"Off Gaz US Pat Off"},{"key":"e_1_2_11_57_1","volume-title":"Battling the wolves of society: the narcotic evil","author":"Rowell EA","year":"1929"},{"key":"e_1_2_11_58_1","unstructured":"MooreAE.Dreams and nightmares oxycodone's early years. Science History Institute.2024. [accessed 17 Jan 2026]. Available from:https:\/\/www.sciencehistory.org\/stories\/magazine\/dreams-and-nightmares\/"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1957.tb05093.x"},{"key":"e_1_2_11_60_1","volume-title":"Evergreen Review","author":"Burroughs WS","year":"1960"},{"key":"e_1_2_11_61_1","first-page":"56","volume-title":"Narcotics","author":"Blanchard BH","year":"1963"},{"key":"e_1_2_11_62_1","doi-asserted-by":"crossref","DOI":"10.2307\/j.ctv19vbgpx","volume-title":"The Narcotic Farm: The Rise and Fall of America's First Prison for Drug Addicts","author":"Campbell ND","year":"2021"},{"key":"e_1_2_11_63_1","volume-title":"Discovering addiction: the science and politics of substance abuse research","author":"Campbell ND","year":"2019"},{"issue":"1","key":"e_1_2_11_64_1","first-page":"1","article-title":"Trends in research on opiate addiction","volume":"24","author":"Isbell H","year":"1956","journal-title":"Trans Stud Coll Physicians Phila"},{"issue":"5","key":"e_1_2_11_65_1","first-page":"721","article-title":"Drug dependence: Its significance and characteristics","volume":"32","author":"Eddy NB","year":"1965","journal-title":"Bull World Health Organ"},{"key":"e_1_2_11_66_1","doi-asserted-by":"crossref","DOI":"10.7560\/330340","volume-title":"Rehab on the range: a history of addiction and incarceration in the American west","author":"Karibo HM","year":"2024"},{"key":"e_1_2_11_67_1","first-page":"63","volume-title":"The National Research Council involvement in the opiate problem, 1928\u20131971","author":"Eddy NB","year":"1928"},{"key":"e_1_2_11_68_1","volume-title":"Studies on drug addiction: with special reference to chemical structure of opium derivatives and allied synthetic substances and their physiological action","author":"Small LF","year":"1938"},{"key":"e_1_2_11_69_1","article-title":"Clinical studies of drug addiction III. A critical review of the withdrawal treatments with method of evaluating abstinence syndromes","volume":"122","author":"Kolb L","year":"1937","journal-title":"Public Health Rep"},{"key":"e_1_2_11_70_1","volume-title":"The pharmacology of the opium alkaloids part 1","author":"Krueger HM","year":"1941"},{"issue":"5","key":"e_1_2_11_71_1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1001\/jama.1943.02840400063025","article-title":"The pharmacology of the opium alkaloids. Part 2","volume":"123","author":"Krueger HM","year":"1943","journal-title":"JAMA"},{"issue":"4","key":"e_1_2_11_72_1","first-page":"569","article-title":"Synthetic substances with morphine\u2010like effect: Clinical experience; potency, side\u2010effects, addiction liability","volume":"17","author":"Eddy NB","year":"1957","journal-title":"Bull World Health Organ"},{"issue":"3","key":"e_1_2_11_73_1","first-page":"387","article-title":"Technical study of the comparative effects of morphine and of certain habit\u2010forming drugs: Eucodal, Dicodide, Dilaudide, Acedicone","volume":"3","author":"Health Organization","year":"1938","journal-title":"Bull Health Organ"},{"key":"e_1_2_11_74_1","volume-title":"The traffic in narcotics","author":"Anslinger HJ","year":"1953"},{"key":"e_1_2_11_75_1","volume-title":"Blitzed: drugs in the third Reich","author":"Ohler N","year":"2017"},{"issue":"1","key":"e_1_2_11_76_1","first-page":"26","article-title":"A note on Eucodal habit in India","volume":"77","author":"Chopra RN","year":"1942","journal-title":"Ind Med Gaz"},{"key":"e_1_2_11_77_1","first-page":"1","article-title":"Drug addiction, medical and social aspects in France","volume":"2","author":"Stern G","year":"1954","journal-title":"Bull Narc"},{"key":"e_1_2_11_78_1","unstructured":"Department of Commerce.Percodan. Official gazette of the United States patent Office 1948;617:35. [accessed 31 Jul 2024]. Available from:https:\/\/archive.org\/details\/officialgazette616unit\/page\/n885"},{"key":"e_1_2_11_79_1","doi-asserted-by":"crossref","DOI":"10.4159\/9780674029910","volume-title":"Dark paradise: a history of opiate addiction in America","author":"Courtwright DT","year":"2001"},{"key":"e_1_2_11_80_1","unstructured":"GladwellMAlpertACourtwrightDSimYSpecterMWastillaLet al.Revisionist history: In Triplicate. Pushkin Industries2022."},{"issue":"3","key":"e_1_2_11_81_1","first-page":"212","article-title":"Percodan on triplicate. The background of the new law","volume":"103","author":"Quinn WF","year":"1965","journal-title":"Calif Med"},{"key":"e_1_2_11_82_1","unstructured":"Subcommittee on narcotics and mentally ill.Report of subcommittee on narcotics and mentally ill: excepted narcotics prescriptions.1963. [accessed 31 Jul 2024]. Available from:https:\/\/babel.hathitrust.org\/cgi\/pt?id=uc1.c029374547&seq=47"},{"issue":"173","key":"e_1_2_11_83_1","first-page":"6526","article-title":"Title 26 \u2010 Internal revenue, 1954","volume":"20","author":"Cunningham GW","year":"1955","journal-title":"Fed Regist"},{"key":"e_1_2_11_84_1","unstructured":"Addicts eat drug \u2018like popcorn\u2019. Press Democrat1961; (p.13). [accessed 31 Jul 2024]. Available from:https:\/\/cdnc.ucr.edu\/?a=d&d=SRPD19611107.1.13"},{"key":"e_1_2_11_85_1","unstructured":"Assembly Committee on Criminal Procedure.Narcotics and Dangerous Drugs. Assembly of the State of California.1963. Nov. [accessed 5 Aug 2024]. Available from:https:\/\/babel.hathitrust.org\/cgi\/pt?id=uc1.31822016322851&seq=1"},{"issue":"138","key":"e_1_2_11_86_1","article-title":"Control bill for drug stirs row","volume":"177","year":"1963","journal-title":"Oakland Tribune"},{"key":"e_1_2_11_87_1","unstructured":"Row over death of Percodan control bill flares up again. San Bernardino Sun1963; (p.7). [accessed 15 Jan 2026]. Available from:https:\/\/cdnc.ucr.edu\/?a=d&d=SBS19630518.1.7"},{"key":"e_1_2_11_88_1","unstructured":"BrownEG.Press release.1963. [accessed 14 Jan 2026]. Available from:https:\/\/archive.org\/details\/f-3717-169\/F3717-181\/page\/9"},{"key":"e_1_2_11_89_1","unstructured":"WymanRW.It's a girl: three terms on the Los Angeles City Council 1953\u20131965; three decades in the Democratice party 1948\u20131978. Regional Oral History Office The Bancroft Library;1953. [accessed 5 Aug 2024]. Available from:https:\/\/archive.org\/details\/girlthreeterms00wymarich\/page\/41"},{"issue":"4","key":"e_1_2_11_90_1","first-page":"21","article-title":"Introducing Empracet with Codeine #4","volume":"370","author":"Burroughs Wellcome Company","year":"1977","journal-title":"West J Med"},{"issue":"10","key":"e_1_2_11_91_1","first-page":"325","article-title":"Current trends in modern medicinals","volume":"123","author":"Holland MO","year":"1951","journal-title":"Am J Pharm Sci Support Public Health"},{"key":"e_1_2_11_92_1","first-page":"289","article-title":"Physical dependence potentiality of analgesics","volume":"3","author":"Cass LJ","year":"1961","journal-title":"Curr Ther Res Clin Exp"},{"key":"e_1_2_11_93_1","unstructured":"BlanchardBH.Exempt narcotic preparations \u2010 telep[hone prescriptions.1962Jan. [accessed 7 Jan 2026]. Available from:https:\/\/archive.org\/details\/f-3717-169\/F3717-166\/page\/n49"},{"key":"e_1_2_11_94_1","unstructured":"U.S. tightens rule on sale of a drug; Written prescription will be required for pain\u2010killer California's complaint. The New York Times1963; (p.20). [accessed 15 Jan 2026]. Available from:https:\/\/www.nytimes.com\/1963\/12\/29\/archives\/us-tightens-rule-on-sale-of-a-drug-written-prescription-will-be.html"},{"issue":"2","key":"e_1_2_11_95_1","first-page":"48","article-title":"Deletion from oral prescription procedure of Dihydcrohydroxycodeinone (oxycodone, Eucodal) compounds","volume":"29","author":"Giordano HL","year":"1964","journal-title":"Fed Regist"},{"key":"e_1_2_11_96_1","unstructured":"An act to amend section 111666.12 of the health and safety code relating to narcotics. Cal Legis Assemb ; Jan 4 1965p. 51."},{"issue":"5","key":"e_1_2_11_97_1","first-page":"40","article-title":"Acetaminophen with the narcotic difference","volume":"127","author":"Endo Pharmaceuticals","year":"1977","journal-title":"West J Med"},{"key":"e_1_2_11_98_1","volume-title":"Physicians' desk reference","author":"Huff BB","year":"1978"},{"key":"e_1_2_11_99_1","first-page":"176","article-title":"New York state's triplicate prescription program","volume":"131","author":"Eadie JL","year":"1993","journal-title":"NIDA Res Mon Ser"},{"issue":"81","key":"e_1_2_11_100_1","first-page":"15151","article-title":"The Boro pharmacy and Bell apothecary; revocation of registrations","volume":"53","author":"Lawn JC","year":"1988","journal-title":"Fed Regist"},{"key":"e_1_2_11_101_1","first-page":"159","article-title":"The Illinois experience in achieving the medical\/regulatory balance required to control prescription drug diversion","volume":"131","author":"Bishop MT","year":"1993","journal-title":"NIDA Res Mon Ser"},{"key":"e_1_2_11_102_1","unstructured":"Annual data: data from the drug abuse warning network (DAWN). NIDA Statistical Series.1988;I(8). [accessed 18 Mar 2026]. Available from:https:\/\/babel.hathitrust.org\/cgi\/pt?id=mdp.39015013991628&seq=1"},{"key":"e_1_2_11_103_1","unstructured":"Annual data: data from the drug abuse warning network (DAWN). NIDA Statistical Series.1985;I(5). [accessed 18 Mar 2026]. Available from:https:\/\/babel.hathitrust.org\/cgi\/pt?id=uc1.c047256513&seq=1"},{"key":"e_1_2_11_104_1","unstructured":"Annual data: data from the drug abuse network (DAWN). NIDA Statistical Series.1987;I(7). [accessed 18 Mar 2026]. Available from:https:\/\/babel.hathitrust.org\/cgi\/pt?id=pur1.32754073486064&seq=1"},{"key":"e_1_2_11_105_1","unstructured":"Annual data: data from the drug abuse warning network (DAWN). NIDA Statistical Series1982;I(2). [accessed 18 Mar 2026]. Available from:https:\/\/babel.hathitrust.org\/cgi\/pt?id=uc1.c047256939&seq=1"},{"key":"e_1_2_11_106_1","unstructured":"BartlelsJR.Drug abuse warning network (DAWN I Anaylsis)1973Nov. [accessed 18 Mar 2026]. Available from:https:\/\/babel.hathitrust.org\/cgi\/pt?id=uc1.31822016341166&seq=1"},{"key":"e_1_2_11_107_1","first-page":"315","article-title":"Outpatient treatment of prescription opioid dependence: Comparison of two methods","volume":"43","author":"Tennant FS","year":"1983","journal-title":"NIDA Res Monogr"},{"key":"e_1_2_11_108_1","first-page":"193","article-title":"The California registration system for Habitues to schedule II drugs","volume":"34","author":"Tennant FS","year":"1980","journal-title":"NIDA Res Mon Ser"},{"key":"e_1_2_11_109_1","unstructured":"IngramC.Bill to ease access to drugs for pain gains. Los Angeles Times1997Jul 16; [accessed 11 Apr 2026]. Available from:https:\/\/www.latimes.com\/archives\/la-xpm-1997-jul-16-mn-13133-story.html"},{"key":"e_1_2_11_110_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198507113130205"},{"key":"e_1_2_11_111_1","unstructured":"Risk Minimization Action Plan (RiskMAP) for Oxycodone Hydrochloride E. [accessed 14 Apr 2026]. Available from:https:\/\/www.industrydocuments.ucsf.edu\/docs\/fqff0254\/"},{"key":"e_1_2_11_112_1","unstructured":"TennantF.Overcoming Opiaphobia & Doing Opioids Right. Pain Treatment Topics2007May; [accessed 14 Apr 2026]. Available from:https:\/\/web.archive.org\/web\/20231103105649\/https:\/\/www.endthepain.org\/learning\/documents\/OvercomingOpiophobia.pdf"},{"key":"e_1_2_11_113_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.1999"},{"key":"e_1_2_11_114_1","unstructured":"OrnsteinCNguyenDWeberTDocs on pharma payroll have blemished records limited credentials. ProPublica2010; [accessed 14 Apr 2026]. Available from:https:\/\/www.propublica.org\/article\/dollars-to-doctors-physician-disciplinary-records"},{"key":"e_1_2_11_115_1","unstructured":"DayB BaerSK.San Gabriel Valley Tribune.2017Nov 16; [accessed 11 Apr 2026]. Available from:https:\/\/www.sgvtribune.com\/2017\/11\/16\/dea-targets-former-west-covina-mayor-in-opioid-investigation\/"},{"key":"e_1_2_11_116_1","unstructured":"AnsonP.Pain news Network2017Nov 16; [accessed 14 Apr 2026]. Available from:https:\/\/www.painnewsnetwork.org\/stories\/2017\/11\/16\/dea-raids-forest-tennants-pain-clinic"},{"key":"e_1_2_11_117_1","unstructured":"Founder and Four Executives of Insys Therapeutics Convicted of Racketeering Conspiracy.2019Feb. [accessed 11 Apr 2026]. Available from:https:\/\/www.justice.gov\/usao-ma\/pr\/founder-and-four-executives-insys-therapeutics-convicted-racketeering-conspiracy"},{"key":"e_1_2_11_118_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2015.302982"},{"key":"e_1_2_11_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.103054"},{"key":"e_1_2_11_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2016.09.002"},{"key":"e_1_2_11_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60334-0"},{"key":"e_1_2_11_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(89)90083-5"},{"key":"e_1_2_11_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00003-6"},{"key":"e_1_2_11_124_1","unstructured":"Fueling an Epidemic Part II: Exposing the Financial Ties Between Opioid Manufacturers and Third Party Advocacy Groups.2017. [accessed 15 Apr 2026]. Available from:https:\/\/tinyurl.com\/ynb3txk7"},{"key":"e_1_2_11_125_1","unstructured":"Letters from Purdue Pharma to Fda in Response to Promotional Questions for Oxycodone Hydrochloride. Vol. PSJ2 Exh 43. MDL 2804 National Prescription Opiate Litigation;1996. [accessed 15 Jan 2026]. Available from:https:\/\/www.industrydocuments.ucsf.edu\/docs\/jxff0232"},{"key":"e_1_2_11_126_1","doi-asserted-by":"publisher","DOI":"10.1086\/713409"},{"key":"e_1_2_11_127_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2022.306951"},{"key":"e_1_2_11_128_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2209870"},{"key":"e_1_2_11_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2025.118180"},{"key":"e_1_2_11_130_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000005460"},{"key":"e_1_2_11_131_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000206209"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.70560","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/add.70560","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.70560","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T08:37:58Z","timestamp":1786610278000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/add.70560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":130,"alternative-id":["10.1111\/add.70560"],"URL":"https:\/\/doi.org\/10.1111\/add.70560","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"2026-01-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"add.70560"}}